Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Heparan sulfate-glucosamine 3-O-sulfotransferase 3B1 (HS3ST3B1) is a type II integral membrane enzyme of the sulfotransferase family, responsible for the specific 3-O-sulfation of glucosamine residues in heparan sulfate during its biosynthesis[1][2][5]. This rare terminal sulfation modification controls the formation of unique heparan sulfate motifs that mediate a range of biological activities—including modulation of protein–ligand interactions, growth factor signaling (such as FGF, VEGF, and TGF-β), and immune cell trafficking[2][3][4]. HS3ST3B1’s enzymatic action creates specialized binding sites required for the entry of pathogens like Herpes simplex virus-1[5], but it also serves roles in normal development (notably in epithelial and glandular morphogenesis[3]), immune regulation, and potentially tissue regeneration. The gene is differentially expressed in immune cells and tissues such as liver and placenta, as well as in various cancers, where altered expression is linked to changes in invasiveness, angiogenesis, or EMT[4][5]. Mouse knockout studies indicate its involvement in organ development and function, particularly in secretory glands[3]. No approved drugs directly target HS3ST3B1, but its role as an entry factor for viruses and as a modifier of cancer cell behavior highlights its potential as a therapeutic target or biomarker in specific contexts.
Not applicable for classic drugs; enzyme’s activity generates 3-O-sulfated heparan sulfate motifs, acting as binding or entry receptors (e.g., for Herpes simplex virus-1)[5]. Modulation of extracellular protein binding (e.g., VEGF, TGF-β) via heparan sulfate structure alteration[4]. Regulation of epithelial–mesenchymal transition through changes in glycosaminoglycan fine structure[4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Heparan sulfate-glucosamine 3-O-sulfotransferase 3B1 (HS3ST3B1).